tiprankstipranks

Abraham Ludomirski Insider Profile

4 Followers
Abraham Ludomirski, Director at Recro Pharma, holds 111.10K shares in Vishay Intertechnology (Ticker: VSH), holds 3.17M shares in Recro Pharma (Ticker: REPH).
tipranks
Abraham Ludomirski

Abraham Ludomirski
Recro Pharma (REPH)
Director

Ranked #45,333 out of 78,624 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-8.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
78.67%
21.33%
A breakdown of Abraham Ludomirski's holdings

Insider Roles

Recro Pharma
(REPH)
Director
Vishay Intertechnology
(VSH)
Director
Roles that Abraham Ludomirski holds in companies

Most Profitable Insider Trade

Stock:
Vishay Intertechnology
(VSH)
Rating:Informative Sell
Date:Oct 30, 2017 - Oct 30, 2018
Return:+16.50%
The most profitable trade made by Abraham Ludomirski

Abraham Ludomirski's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Recro Pharma
May 23, 2016
Director
Informative Sell
461.23K
$7.92M
Vishay Intertechnology
Jan 02, 2020
Director
Uninformative Buy
$2.15M
List of latest transactions for each holding click on a transaction to see Abraham Ludomirski's performance on stock

Abraham Ludomirski insider profile FAQ

What is the percentage of profitable transactions made by Abraham Ludomirski?
The percentage of profitable transactions made by Abraham Ludomirski is 50%.
    What is the average return per transaction made by Abraham Ludomirski?
    The average return per transaction made by Abraham Ludomirski is -8.50%.
      What stocks does Abraham Ludomirski hold?
      Abraham Ludomirski holds: REPH, VSH stocks.
        What was Abraham Ludomirski’s latest transaction?
        Abraham Ludomirski latest transaction was an Uninformative Buy of ―.
          What was Abraham Ludomirski's most profitable transaction?
          Abraham Ludomirski’s most profitable transaction was an Informative Sell of VSH stock on October 30, 2017. The return on the trade was 16.50%.
            What is Abraham Ludomirski's role in Recro Pharma?
            Abraham Ludomirski's role in Recro Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.